scholarly article | Q13442814 |
P356 | DOI | 10.1002/1521-2254(200011/12)2:6<416::AID-JGM142>3.0.CO;2-Y |
P698 | PubMed publication ID | 11199262 |
P2093 | author name string | Klatzmann D | |
Cosset FL | |||
Marodon G | |||
Pioche-Durieu C | |||
Zhao-Emonet JC | |||
P2860 | cites work | SCL binds the human homologue of DRG in vivo | Q22008035 |
At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells | Q29618360 | ||
High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes | Q34003623 | ||
Transcriptional interference in avian retroviruses—implications for the promoter insertion model of leukaemogenesis | Q34257238 | ||
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells | Q35604467 | ||
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins | Q36487614 | ||
Identification and characterization of a T-cell-specific enhancer adjacent to the murine CD4 gene | Q36747167 | ||
Negative control region at the 5' end of murine leukemia virus long terminal repeats | Q36766559 | ||
Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer | Q36836984 | ||
Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor. | Q37149903 | ||
Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes | Q37401979 | ||
Retroviruses as vectors | Q40537182 | ||
Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter | Q41266120 | ||
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers | Q41342219 | ||
Site-directed mutagenesis of virtually any plasmid by eliminating a unique site | Q42611278 | ||
Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation | Q43993308 | ||
Evaluation of Lymphoid-Specific Enhancer Addition or Substitution in a Basic Retrovirus Vector | Q44045500 | ||
Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope | Q45767602 | ||
Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo | Q45865684 | ||
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients | Q45866834 | ||
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. | Q45866838 | ||
Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase delta TK gene | Q58659768 | ||
P433 | issue | 6 | |
P304 | page(s) | 416-425 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Journal of Gene Medicine | Q15746377 |
P1476 | title | T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer | |
P478 | volume | 2 |
Q34120983 | Absence of functional and structural abnormalities associated with expression of EGFP in the retina |
Q25255153 | Coordinate enhancement of transgene transcription and translation in a lentiviral vector |
Q34715929 | Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors |
Q37801839 | Physiological and tissue-specific vectors for treatment of inherited diseases |
Q36716418 | Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines. |
Q42807227 | Replicative retroviral vectors for cancer gene therapy |
Q36457016 | Retrovirus vectors: toward the plentivirus? |